CDMO-CRO Integration: Transforming the Landscape of Clinical Research

During the past several decades, drug development sponsors have implemented a number of approaches to reduce operating inefficiencies focusing largely on within-function process improvements.  Recently, sponsors have turned their attention to reducing the inefficiencies between  functional collaborations. Siloed functions (e.g., manufacturing and clinical) typically encounter collaboration inefficiencies including poor knowledge sharing and data transfer, delays in the transition of tasks and activities, and poor and incomplete communication and coordination.  This session presents the results of  a  new empirical study that quantifies the net financial benefit of efficiencies created by the integration of CDMO and CRO collaborations.